FDA Inspection 1194198 — Taro Pharmaceutical Industries Ltd.
The FDA completed an inspection of Taro Pharmaceutical Industries Ltd. on Dec 8, 2022 in Haifa Bay. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Haifa Bay (Israel)